Judy DiClemente | IR |
Nikhil Lalwani | President and CEO |
Steve Carey | CFO |
Christopher Mutz | Head, Rare Disease |
Elliot Wilbur | Raymond James |
Brandon Folkes | Cantor Fitzgerald |
Greg Fraser | Truist Securities |
Good morning, everyone. My name is Todd, and I'll be your conference operator. At this time, I'd like to welcome everyone to ANI Pharmaceuticals Third Quarter 2022 Financial Results. [Operator Instructions] As a reminder, this conference call is being recorded today, November 9, 2022. It is now my pleasure to turn the floor over to Ms.